X

Vous n'êtes pas connecté

Maroc Maroc - ONCOLOGYNEWS.COM.AU - A La Une - Hier 07:02

Bacterial vaccine shows promise as cancer immunotherapy

Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of cancer vaccines that take advantage of bacteria’s natural tumour-targeting properties. These microbial cancer vaccines can be personalised to attack each individual’s primary tumour and metastases, and may even prevent future recurrences. In [...]

Articles similaires

Bacterial vaccine shows promise as cancer immunotherapy

oncologynews.com.au - 07:02

Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of...

Immune cell discovery offers new potential for cancer immunotherapy

oncologynews.com.au - 05/Nov 16:02

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...

New Plug-and-Play Tool for Monitoring T-cell Immunotherapy Outcomes

medindia.net - 09:05

Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and effectiveness of...

New Plug-and-Play Tool for Monitoring T-cell Immunotherapy Outcomes

medindia.net - 09:05

Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and effectiveness of...

Discovery finds how ovarian cancer disables immune cells

oncologynews.com.au - 07/Nov 13:40

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumours use to cripple immune cells and impede their attack—blocking the...

Re-engineered, blue light-activated immune cells penetrate and kill solid tumours

oncologynews.com.au - 07/Nov 16:00

Immunotherapies that mobilise a patient’s immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell...

In landmark study, immunotherapy boosts survival of advanced Hodgkin lymphoma

oncologynews.com.au - 06:54

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92...

In landmark study, immunotherapy boosts survival of advanced Hodgkin lymphoma

oncologynews.com.au - 06:54

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92...

A remote-controlled car for cancer immunotherapy

oncologynews.com.au - 07/Nov 15:55

Ludwig Cancer Research scientists have devised new types of chimaeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be...

New Option For Treating Prostate Cancer

eurasiareview.com - 10/Nov 00:29

Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumour is still...

Les derniers communiqués

  • Aucun élément